These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 36771113)

  • 21. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naringenin prevents ischaemic stroke damage via anti-apoptotic and anti-oxidant effects.
    Wang K; Chen Z; Huang J; Huang L; Luo N; Liang X; Liang M; Xie W
    Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):862-871. PubMed ID: 28453191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron aggravates hepatic insulin resistance in the absence of inflammation in a novel db/db mouse model with iron overload.
    Altamura S; Müdder K; Schlotterer A; Fleming T; Heidenreich E; Qiu R; Hammes HP; Nawroth P; Muckenthaler MU
    Mol Metab; 2021 Sep; 51():101235. PubMed ID: 33872860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice.
    Daniel T; Ben-Shachar M; Drori E; Hamad S; Permyakova A; Ben-Cnaan E; Tam J; Kerem Z; Rosenzweig T
    J Nutr Biochem; 2021 Dec; 98():108867. PubMed ID: 34571189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway.
    Chtourou Y; Fetoui H; Jemai R; Ben Slima A; Makni M; Gdoura R
    Eur J Pharmacol; 2015 Jan; 746():96-105. PubMed ID: 25446569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between pancreas steatosis and the risk of metabolic syndrome and insulin resistance in Chinese adolescents with concurrent obesity and non-alcoholic fatty liver disease.
    Chiyanika C; Chan DFY; Hui SCN; So HK; Deng M; Yeung DKW; Nelson EAS; Chu WCW
    Pediatr Obes; 2020 Sep; 15(9):e12653. PubMed ID: 32351030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PVP- coated naringenin nanoparticles for biomedical applications - In vivo toxicological evaluations.
    Kumar RP; Abraham A
    Chem Biol Interact; 2016 Sep; 257():110-8. PubMed ID: 27417253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naringenin Prevents Oxidative Stress and Inflammation in LPS-Induced Liver Injury through the Regulation of LncRNA-mRNA in Male Mice.
    Ji M; Deng Z; Rong X; Li R; You Z; Guo X; Cai C; Zhao Y; Gao P; Cao G; Li B; Yang Y
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GATA3 as an immunomodulator in obesity-related metabolic dysfunction associated with fatty liver disease, insulin resistance, and type 2 diabetes.
    El-Arabey AA; Abdalla M
    Chem Biol Interact; 2022 Oct; 366():110141. PubMed ID: 36058260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective amelioration of hepatic inflammation and insulin response in high fat diet-fed rats via regulating AKT/mTOR signaling: Role of Lepidium sativum seed extracts.
    Abdulmalek SA; Fessal M; El-Sayed M
    J Ethnopharmacol; 2021 Feb; 266():113439. PubMed ID: 33017634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
    Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [METABOLIC FEATURES OF ADIPOSE TISSUE AND CLINICAL SIGNIFICANCE OF ADIPOKINS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (REVIEW)].
    Pivtorak K; Yakovleva O; Pivtorak N; Fedzhaga I; Doroshkevich I
    Georgian Med News; 2021; (316-317):135-141. PubMed ID: 34511460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral and central signals in the control of eating in normal, obese and binge-eating human subjects.
    Hellström PM; Geliebter A; Näslund E; Schmidt PT; Yahav EK; Hashim SA; Yeomans MR
    Br J Nutr; 2004 Aug; 92 Suppl 1():S47-57. PubMed ID: 15384323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.
    Jung UJ; Choi MS
    Int J Mol Sci; 2014 Apr; 15(4):6184-223. PubMed ID: 24733068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update.
    Joshi R; Kulkarni YA; Wairkar S
    Life Sci; 2018 Dec; 215():43-56. PubMed ID: 30391464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations.
    Theofilis P; Vordoni A; Kalaitzidis RG
    World J Gastroenterol; 2022 Oct; 28(39):5691-5706. PubMed ID: 36338895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Honokiol Improves Insulin Resistance, Hepatic Steatosis, and Inflammation in Type 2 Diabetic
    Kim YJ; Jung UJ
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31075962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of leptin and hunger-satiety ratings in obese women.
    Heini AF; Lara-Castro C; Kirk KA; Considine RV; Caro JF; Weinsier RL
    Int J Obes Relat Metab Disord; 1998 Nov; 22(11):1084-7. PubMed ID: 9822946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.
    Komiya C; Tsuchiya K; Shiba K; Miyachi Y; Furuke S; Shimazu N; Yamaguchi S; Kanno K; Ogawa Y
    PLoS One; 2016; 11(3):e0151511. PubMed ID: 26977813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.